# A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy

> **NCT03153293** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 159 (actual)

## Conditions studied

- Leber Hereditary Optic Neuropathy

## Interventions

- **DRUG:** rAAV2-ND4

## Key facts

- **NCT ID:** NCT03153293
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-27
- **Primary completion:** 2020-01-15
- **Final completion:** 2025-01-15
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2020-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153293, "A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03153293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*